Skip to main content
. 2022 Feb 15;12(2):793–804.

Figure 1.

Figure 1

Breast cancer patient survival by H2AX expression. A. Disease-free survival by H2AX expression in TCGA breast cancer cohort. H2AX high: n=51, H2AX low: n=947. B. Overall survival by H2AX expression in TCGA breast cancer cohort. H2AX high: n=55, H2AX low: n=1034. C. Disease-specific survival by H2AX in METABTIC breast cancer cohort. H2AX high: n=72, H2AX low: n=1351. Red and blue lines represent H2AX high and low expression patients.